234 related articles for article (PubMed ID: 28404921)
1. Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.
Ma Y; Chen Y; Lin J; Liu Y; Luo K; Cao Y; Wang T; Jin H; Su Z; Wu H; Chen X; Cheng J
Oncotarget; 2017 Apr; 8(17):28660-28671. PubMed ID: 28404921
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
3. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis.
Ren J; Kuang TH; Chen J; Yang JW; Liu YX
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):120-130. PubMed ID: 28121346
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-21 as a biomarker for the detection of various carcinomas: an updated meta-analysis based on 36 studies.
Wu K; Li L; Li S
Tumour Biol; 2015 Mar; 36(3):1973-81. PubMed ID: 25527152
[TBL] [Abstract][Full Text] [Related]
7. The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis.
Zhang Y; Lin J; Huang W; Cao Y; Liu Y; Wang T; Zhong W; Wang D; Mao R; Chen X
Onco Targets Ther; 2017; 10():3193-3201. PubMed ID: 28721069
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies.
Gao Y; Cai Q; Huang Y; Li S; Yang H; Sun L; Chen K; Wang Y
Oncotarget; 2016 Jun; 7(23):34498-506. PubMed ID: 27153564
[TBL] [Abstract][Full Text] [Related]
9. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y
Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.
Shen H; Che K; Cong L; Dong W; Zhang T; Liu Q; Du J
Oncotarget; 2017 May; 8(22):36812-36823. PubMed ID: 28415658
[TBL] [Abstract][Full Text] [Related]
11. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
Jiang JX; Zhang N; Liu ZM; Wang YY
Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
[TBL] [Abstract][Full Text] [Related]
12. The Accuracy of Single MicroRNAs in Peripheral Blood to Diagnose Ovarian Cancer: An Updated Meta-Analysis.
Cui Y; Hong S; Zhu X
Dis Markers; 2020; 2020():1075942. PubMed ID: 32025275
[TBL] [Abstract][Full Text] [Related]
13. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility of microRNA-21 as novel biomarker for diagnosing human cancers.
Shen L; Wan Z; Ma Y; Wu L; Liu F; Zang H; Xin S
Tumour Biol; 2015 Mar; 36(3):1993-2005. PubMed ID: 25431259
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
Wu B; Zhen K; Guo L; Sun C
Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
[No Abstract] [Full Text] [Related]
17. Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis.
Aalami AH; Abdeahad H; Shoghi A; Mesgari M; Amirabadi A; Sahebkar A
Expert Rev Mol Diagn; 2022 Feb; 22(2):201-211. PubMed ID: 34906021
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of microRNA-221/222 expression in cancers: evidence from 1,204 subjects.
Wang J; Liu S; Sun GP; Wang F; Zou YF; Jiao Y; Ning J; Xu J
Int J Biol Markers; 2014 Jun; 29(2):e129-41. PubMed ID: 24474451
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis.
Zheng Q; Chen C; Guan H; Kang W; Yu C
Oncotarget; 2017 Jul; 8(28):46611-46623. PubMed ID: 28402940
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review.
Thi Chung Duong T; Nguyen THN; Thi Ngoc Nguyen T; Huynh LH; Ngo HP; Thi Nguyen H
Cancer Epidemiol; 2022 Apr; 77():102097. PubMed ID: 35030348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
